Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5563
Source ID: NCT02745470
Associated Drug: Lixisenatide
Title: Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus
Interventions: DRUG: Lixisenatide|OTHER: Placebo
Outcome Measures: Primary: Difference of BOLD (Blood oxygenation level-dependent) signal in hypothalamus, 10min (40 min after injection)|Whole brain connectivity, 20min (50 min after injection) | Secondary: appetite change, Visual analoge scale-questionnaire consisting of 8 questions (Flint, Raben, Blundell, \& Astrup, 2000), -30min, 45min(after fMRI), 70min(after buffet)|mood change, Visual analoge scale-questionnaire consisting of 16 questions (Boggieo et al., 2008), -30min, 45min(after fMRI), 70min(after buffet)|intake of food in the buffet, It will be provided quantified juice and milk , boiled eggs, bread , bananas and chocolate bars. Participants may eat freely for 20 minutes. Then measure the intake of participants. Compares whether the difference in food intake pattern ., 50min
Sponsor/Collaborators: Sponsor: Seoul National University Hospital | Collaborators: Seoul National University
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 30
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
Start Date: 2016-02
Completion Date: 2016-12
Results First Posted:
Last Update Posted: 2017-11-29
Locations: Seoul National University Hospital, Seoul, 110-744, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT02745470